Lam Research Corporation (LRCX)
Is Lam Research (LRCX) Outperforming Other Computer and Technology Stocks This Year?
Here is how Lam Research (LRCX) and Aehr Test Systems (AEHR) have performed compared to their sector so far this year.
Lam Research (LRCX) Recently Broke Out Above the 50-Day Moving Average
After reaching an important support level, Lam Research (LRCX) could be a good stock pick from a technical perspective. LRCX surpassed resistance at the 50-day moving average, suggesting a short-term bullish trend.
Lam Research's DRAM Push Gains Steam: Can It Boost Growth Further?
LRCX's DRAM push gains momentum as AI-driven HBM demand, advanced memory nodes and growing tool adoption expand its growth opportunities.
Lam Research's Etch Moat Could Become the Most Profitable Lever in Next‑Gen Semiconductor Manufacturing
Shares of Lam Research (NASDAQ:LRCX | LRCX Price Prediction) are rallying back rapidly after a pretty terrifying moment that saw nearly 42% of its value wiped out in just over a month.
Why Lam Research (LRCX) is a Top Stock for the Long-Term
Finding strong, market-beating stocks with a positive earnings outlook becomes easier with the Focus List, a top feature of the Zacks Premium portfolio service.
Elon Musk's Newest Factory is 15X The Size of The Pentagon. Micron and Memory Stocks Should be Terrified.
SpaceX released renderings of its 100,000,000 square foot Terrafab facility last week, a building roughly 15 times the size of the Pentagon and designed in part to break the memory oligopoly controlled by Micron, SK Hynix, and Samsung.
Lam Research Enters Panel-Level Packaging: Is This a Growth Catalyst?
LRCX expands into PLP as larger AI chips drive demand, targeting a fast-growing advanced-packaging opportunity.
Lam Research (LRCX) Upgraded to Strong Buy: Here's Why
Lam Research (LRCX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #1 (Strong Buy).
Wall Street Analysts See Lam Research (LRCX) as a Buy: Should You Invest?
Investors often turn to recommendations made by Wall Street analysts before making a Buy, Sell, or Hold decision about a stock. While media reports about rating changes by these brokerage-firm employed (or sell-side) analysts often affect a stock's price, do they really matter?
Lam Research Plunges 16% in a Month: Should You Still Buy the Stock?
LRCX's 16% monthly fall contrasts with record revenues, strong AI equipment demand and rising earnings, strengthening the case for buying the stock.
Best Momentum Stocks to Buy for August 3rd
LRCX, VRT and MBIN made it to the Zacks Rank #1 (Strong Buy) momentum stocks list on August 3rd, 2026.
Lam Research: My Watch List Resolved Bullish, And The Stock Fell 7% Anyway
In its July 29 Q4 print, Lam Research saw revenue $6.72B against a $6.60B guide; EPS $1.82, against a $1.65 guide; gross margin 52%, which is the highest quarterly level in twenty years, FY2026 revenue $23.2B; and a fourth consecutive record quarter. Customer advance deposits had fallen three quarters running, from $2.7B to $2.25B to $2.22B, and I wrote in the July 23 piece that this is the first thing that softens if an order book is quietly rolling over behind a strong revenue headline. The record quarter was mostly expected. What changed is that the market handed back roughly a sixth of the price while the evidence for the earnings moved the other way - and it did it for a reason that is about the sector's funding conditions rather than about this company's cash flows.
